GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **1676 - 1700** of **4050** in total

« First

‹ Prev

…

64

65

66

67

68

69

70

71

72

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID	Arbitrary Fluorescence Units (AFU) ▲
IgM	Patient 1	22	moderate	G78255UI	147
IgM	Patient 3	4	mild	G78074HX	147
IgM	Patient 4	12	mild	G00065MO	147
IgM	Patient 4	12	mild	G19868AX	147
IgM	Patient 2	15	mild	G39023AU	148
IgG	Patient 2	3	mild	G81315DD	148
IgG	Patient 3	11	mild	G16579HJ	148
IgM	Patient 3	-180	mild	G32611KT	148
IgM	Patient 3	4	mild	G58547FH	148
IgM	Patient 4	12	mild	G52880ZN	148
IgM	Patient 4	12	mild	G78255UI	148
IgG	Patient 3	11	mild	G84224TW	149
IgG	Patient 4	12	mild	G94576MN	149
IgM	Patient 4	12	mild	G89993FE	149
IgG	Patient 2	24	mild	G92022ML	150
IgM	Patient 1	6	moderate	G09482NW	150
IgM	Patient 3	-180	mild	G84224TW	150
IgM	Patient 3	-180	mild	G92022ML	150
IgM	Patient 3	11	mild	G29011JC	150
IgG	Patient 4	12	mild	G98068PA	150
IgG	Patient 2	3	mild	G92022ML	151
IgM	Patient 2	3	mild	G68703KI	151
IgM	Patient 3	11	mild	G00065MO	151
IgG	Patient 4	12	mild	G53168IY	151
IgM	Patient 4	12	mild	G26125KY	151